BMC Health Services Research

official impact factor 1.72

Open Access Research article

Impact of patient characteristics on the risk of influenza/ILI-related complications

Debra E Irwin1, Lisa B Weatherby1, Wen-Yi Huang2,3, Daniel M Rosenberg4, Suzanne F Cook2 and Alexander M Walker1*

Author Affiliations

1 Ingenix Pharmaceutical Services, Epidemiology Division, Newton Lower Falls, Massachusetts, USA

2 Worldwide Epidemiology, GlaxoSmithKline, Research Triangle Park, North Carolina, USA

3 Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA

4 Worldwide Epidemiology, GlaxoSmithKline, Greenford, UK

For all author emails, please log on.

BMC Health Services Research 2001, 1:8 doi:10.1186/1472-6963-1-8

Published: 21 August 2001

Abstract

Background

We sought to quantify the impact of patient characteristics on complications and health care costs associated with influenza and influenza-like illness (ILI) in a nonelderly population.

Methods

Patients with medical reimbursement claims for influenza in the 1996–1997 season were identified from the automated database of a large private New England Insurer (NEI). Influenza care during the 21- day follow-up period was characterized according to age, gender, vaccine status, co-morbidities, prior influenza/ILI episodes, treatments, and recent health care costs and related diagnoses.

Results

There were 6,241 patients. Approximately 20% had preexisting chronic lung disease. Overall, 23% had health care services for possible complications, among which respiratory diagnoses were the most common (13%). Two percent of the influenza/ILI episodes involved hospitalization, with a median stay of five days. Factors most strongly predictive of hospitalizations and complications were preexisting malignancy (hospitalizations OR = 3.7 and complications OR = 2.4), chronic heart disease (OR = 3.2 and OR = 1.8), diabetes (OR = 2.2 and OR = 1.7) and recent illnesses that would have counted as complications had they occurred during an influenza/ILI episode (hospitalizations OR = 3.2 and complications OR = 1.5). The same factors affected influenza-related costs and total costs of care as dramatically as they affected complication rates.

Conclusions

Influenza/ILI-related costs are driven by the characteristics that predict complications of influenza. Patients with chronic illness and those with recent acute respiratory events are the most likely to experience complications and hospitalizations.